The authors had earlier described how BenevolentAI’s proprietary KG, queried by a suite of algorithms, enabled the identification of baricitinib, a numb-associated kinase (NAK) inhibitor, to suppress clathrin-mediated endocytosis and thereby inhibit viral infection of cells. This evidence concerns the gene TBK1 and viral infectious disease.